Immediate multivessel revascularization after myocardial infarction: change of strategy?

Piera Capranzano1, Luca Lombardo1

  • 1Cardiovascular Department, Policlinico Hospital, University of Catania, Catania.

Insights

For ST-elevation myocardial infarction (STEMI) patients with multivessel disease (MVD), complete revascularization is recommended. Recent studies show immediate or delayed multivessel PCI offer similar outcomes for stable patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Multivessel coronary artery disease (MVD) is common in ST-segment elevation myocardial infarction (STEMI) patients.
  • Complete revascularization offers benefits over treating only the culprit lesion in STEMI patients.

Purpose of the Study:

  • To discuss recent studies on the optimal timing of complete revascularization in STEMI patients with MVD.
  • To evaluate the clinical implications of immediate versus deferred multivessel PCI.

Main Methods:

  • Review of recent studies comparing immediate versus deferred multivessel PCI in STEMI patients.
  • Analysis of outcomes in haemodynamically stable STEMI patients with MVD.

Main Results:

  • Recent studies indicate non-inferiority of immediate versus delayed multivessel PCI.
  • Optimal timing for non-culprit lesion treatment in stable STEMI patients remains under evaluation.

Conclusions:

  • Current European guidelines recommend complete revascularization for stable STEMI patients with MVD.
  • The choice between immediate and deferred multivessel PCI is still debated, with recent data suggesting comparable outcomes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
619
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741